⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL791435 | 0.67 | — | — | |
| SCHEMBL31429176 | 0.67 | — | — | |
| SCHEMBL5027915 | 0.67 | — | — | |
| SCHEMBL818856 | 0.67 | — | — | |
| SCHEMBL11673253 | 0.63 | — | — | |
| SCHEMBL5924311 | 0.62 | — | — | |
| SCHEMBL10175674 | 0.62 | — | — | |
| SCHEMBL368280 | 0.62 | — | — | |
| SCHEMBL979504 | 0.61 | — | — | |
| SCHEMBL1298896 | 0.60 | ATM (0.31) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0153615-B1 | PROCESS FOR THE PREPARATION OF TETRONIC ACID | LONZA AG (CH) | 1989-04-26 | — | — | EP | claimed |
| US-20260138991-A1 | SEMI-SATURATED BICYCLIC DERIVATIVES AND RELATED USES | MOMA THERAPEUTICS INC (US) | 2026-05-21 | — | — | US | disclosed |
| EP-4735426-A1 | HETEROAROMATIC DHODH INHIBITORS | Immunic AG (DE) | 2026-05-06 | — | — | EP | disclosed |
| EP-4705298-A2 | SEMI-SATURATED BICYCLIC DERIVATIVES AND RELATED USES | Moma Therapeutics, Inc. (US) | 2026-03-11 | — | — | EP | disclosed |
| US-12559508-B2 | Semi-saturated bicyclic derivatives and related uses | MOMA THERAPEUTICS, INC. (US) | 2026-02-24 | — | — | US | disclosed |
| US-20250230171-A1 | SEMI-SATURATED BICYCLIC DERIVATIVES AND RELATED USES | MOMA THERAPEUTICS, INC. | 2025-07-17 | — | — | US | disclosed |
| WO-2025003402-A1 | HETEROAROMATIC DHODH INHIBITORS | IMMUNIC AG (DE) | 2025-01-02 | — | — | WO | disclosed |
| WO-2024211836-A2 | SEMI-SATURATED BICYCLIC DERIVATIVES AND RELATED USES | MOMA THERAPEUTICS, INC. (US) | 2024-10-10 | — | — | WO | disclosed |
| US-20240043450-A1 | NEW COMPOUND | JANSSEN PHARMACEUTICA NV (BE) | 2024-02-08 | — | — | US | disclosed |
| EP-4217347-A1 | NEW COMPOUNDS | JANSSEN Pharmaceutica NV (BE) | 2023-08-02 | — | — | EP | disclosed |
| EP-2102199-A1 | ANTIBACTERIAL POLYCYCLIC UREA COMPOUNDS | AstraZeneca AB (SE) | 2009-09-23 | — | — | EP | disclosed |
| EP-2064209-A1 | PYRROLE DERIVATIVES WITH ANTIBACTERIAL ACTIVITY | AstraZeneca AB (SE) | 2009-06-03 | — | — | EP | disclosed |
| WO-2008068470-A1 | ANTIBACTERIAL POLYCYCLIC UREA COMPOUNDS | ASTRAZENECA AB (SE) | 2008-06-12 | — | — | WO | disclosed |
| US-20080132546-A1 | CHEMICAL COMPOUNDS | ASTRAZENECA AB (SE) | 2008-06-05 | — | — | US | disclosed |
| WO-2008020227-A2 | ANTIBACTERIAL PYRROLECARBOXAMIDES | ASTRAZENECA AB (SE) | 2008-02-21 | — | — | WO | disclosed |
| WO-2008020222-A1 | PYRROLE DERIVATIVES WITH ANTIBACTERIAL ACTIVITY | ASTRAZENECA AB (SE) | 2008-02-21 | — | — | WO | disclosed |
| US-5808014-A | Process for the preparation of arlazotetronic acid derivatives | LONZA, AG (CH) | 1998-09-15 | — | — | US | disclosed |
| EP-0827958-A1 | Method for the preparation of arylazotetronic acid derivatives | LONZA AG (CH) | 1998-03-11 | — | — | EP | disclosed |
| EP-0418020-A2 | Cephalosporinderivatives, process for their preparation and pharmaceutical compositions | BEECHAM GROUP PLC (GB) | 1991-03-20 | — | — | EP | disclosed |
| EP-0153615-A1 | Process for the preparation of tetronic acid | LONZA AG (CH) | 1985-09-04 | — | — | EP | disclosed |